Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine/Melphalan and Low-Dose Total Body Irradiation: A Single Center Analysis
Conclusion: The current study proved that disease status at allo-HCT were mainly in non-remission. In such a situation, RIC using Flu/Mel/TBI was well tolerated with relatively low NRM, and was sufficient to allow engraftment for elderly or frail patients with hematopoietic malignancies.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - Category: Hematology Authors: Mino, T., Katayama, Y., Terasaki, T., Kochi, Y., Jinnouchi, F., Okatani, T., Imanaka, R., Kyo, K., Itagaki, M., Katsutani, S., Muta, T., Iwato, K., Asaoku, H. Tags: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Fungal Infections | Leukemia | Lymphoma | Methotrexate | Myelodysplastic Syndrome | Pneumonia | Prograf | Stem Cell Therapy | Stem Cells | Study | Tacrolimus | Toxicology | Transplants